MBS488348 | Anti-CD80 [IDEC-114 (Galiximab)]

Anti-CD80 [IDEC-114 (Galiximab)] | MBS488348 | Mybiosource

Product Short Name: [CD80]

Product Name Synonyme: [B7-1; T-lymphocyte activation antigen CD80; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7]

Other Names: [T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; CD80 molecule; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7; CD_antigen: CD80]

Product Gene Name: [CD80]

Product Gene Name Synonyme: N/A

Other Gene Names: [CD80; CD80; B7; BB1; B7-1; B7.1; LAB7; CD28LG; CD28LG1; CD28LG; CD28LG1; LAB7; B7]

Clonality: Monoclonal

Isotype: Rabbit IgG, Lambda

Clone: [IDEC-114]

Host: N/A

Reactivity: Human

Specificity: Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80. CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells, and expressed consitutively on various subtypes of B-cell lymphomas.

Purity: Protein A Affinity Purified

Form: N/A

Concentration: 1 mg/ml

Storage Stability: Store at 4 degree C for up to 3 months. For longer storage, aliquot and store at -20 degree C.

Tested Application: Block (BL), Modulate, Flow Cytometry (FC/FACS), Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP), Immunohistochemistry (IHC)